Archive for April, 2007

Shire edges 2007 revenue guidance higher; Q1 EPS jumps 39 pct UPDATE - Forbes

Shire edges 2007 revenue guidance higher; Q1 EPS jumps 39 pct UPDATEForbes, NY - Apr 25, 2007Sales beat forecasts, climbing 29 pct to 528 mln usd, boosted by a strong performance from Adderall XR and new products launched last year. …

Read full story

Comments

Prescribing a problem: Part III (4/12) - DU The Duquesne Duke

Prescribing a problem: Part III (4/12)DU The Duquesne Duke, PA - Apr 24, 2007B. has also tried many other prescription drugs like Percocet, Xanax, Vicodin and Adderall. He prefers Oxycontin over the others. …

Read full story

Comments

Comparing drugs, meds - Martinsburg Journal

Comparing drugs, medsMartinsburg Journal, WV - 6 hours agoOur annual 350 million doses of Ritalin, Adderall and Dexedrine is triple the doses of all other countries combined. Will these prescriptions counteract …

Read full story

Comments

FTSE 100 movers: JP Morgan keen on Shire - ShareCast

FTSE 100 movers: JP Morgan keen on ShireShareCast, UK - 9 hours agoThe broker noted that the company’s flagship ADHD product, Adderall XR, showed a 14% price benefit, which accounted for two-thirds of its growth in the …Strong start to year for Shire ShareCastall 3 news articles

Read full story

Comments

Prescribing a problem: Part five - DU The Duquesne Duke

Prescribing a problem: Part fiveDU The Duquesne Duke, PA - 5 hours agoEven after a “scary” bout with amphetamine psychosis, L., a junior at Duquesne, says he still takes Adderall when he needs it to read or study. …Prescribing a problem: PART 4 DU The Duquesne DukePrescribing a problem: Part III (4/12) DU The Duquesne Dukeall 3 news articles

Read full story

Comments

Shire storms ahead with strong sales across the board - Pharma Times (subscription)

Shire storms ahead with strong sales across the boardPharma Times (subscription), UK - 28 minutes agoThe firm has just completed its $2.6 billion acquisition of the USA's New River Pharmaceuticals which gives it full control of the heir to Adderall XR, …

Read full story

Comments

Shire edges 2007 revenue guidance higher; Q1 EPS jumps 39 pct - Hemscott

Shire edges 2007 revenue guidance higher; Q1 EPS jumps 39 pctHemscott, UK - 11 hours agoFirst-quarter revenues have been driven by continuing strong growth of Adderall XR, the group's top-selling hyperactivity drug which accounts for almost …

Read full story

Comments

Shire nudges up revenue forecast after strong Q1 - Reuters

Shire nudges up revenue forecast after strong Q1Reuters - 10 hours agoRevenues rose a stronger-than-expected 29 percent to $528 million, helped by a 21 percent rise in sales of top-selling hyperactivity drug Adderall XR and a …

Read full story

Comments

Premarket Movers: Corning Rises - Forbes

Premarket Movers: Corning RisesForbes, NY - 9 hours agoThe company said recent product launches have been successful and its attention deficit hyperactivity disorder drug Adderall is holding its share of a …

Read full story

Comments

Strong start to year for Shire - ShareCast

Strong start to year for ShireShareCast, UK - 9 hours ago… as the drug developer reported a strong start to the year, with revenues up 29% during the first quarter, boosted by rising sales of Adderall XR. …

Read full story

Comments

· « Previous entries